Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Bryan D Choi, Carter M Suryadevara, Patrick C Gedeon, James E Herndon, Luis Sanchez-Perez, Darell D Bigner, John H Sampson

Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 2014, 21 (1): 189-90

Chimeric antigen receptors (CAR)-transduced T cells hold great promise in the treatment of malignant disease. Here, we demonstrate that intracerebral injection with a human, epidermal growth factor receptor variant III (EGFRvIII)-specific, third generation CAR successfully treats glioma in mice. Importantly, these results endorse clinical translation of this CAR in patients with EGFRvIII-expressing brain tumors.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma. Chan-Juan Shen, Yu-Xiu Yang, Ethan Q Han, Na Cao, Yun-Fei Wang, Yi Wang, Ying-Ying Zhao, Li-Ming Zhao, Jian Cui, Puja Gupta, Albert J Wong, Shuang-Yin Han Journal of Hematology & Oncology 2013, 6: 33

Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen. Masasuke Ohno, Atsushi Natsume, Ken Ichiro Iwami, Hidetaka Iwamizu, Kana Noritake, Daiki Ito, Yuki Toi, Motokazu Ito, Kazuya Motomura, Jun Yoshida, Kazuhiro Yoshikawa, Toshihiko Wakabayashi Cancer Science 2010, 101 (12): 2518-24

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Richard A Morgan, Laura A Johnson, Jeremy L Davis, Zhili Zheng, Kevin D Woolard, Elizabeth A Reap, Steven A Feldman, Nachimuthu Chinnasamy, Chien-Tsun Kuan, Hua Song, Wei Zhang, Howard A Fine, Steven A Rosenberg Human Gene Therapy 2012, 23 (10): 1043-53

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. John H Sampson, Bryan D Choi, Luis Sanchez-Perez, Carter M Suryadevara, David J Snyder, Catherine T Flores, Robert J Schmittling, Smita K Nair, Elizabeth A Reap, Pamela K Norberg, James E Herndon, Chien-Tsun Kuan, Richard A Morgan, Steven A Rosenberg, Laura A Johnson Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2014 February 15, 20 (4): 972-84

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. Hongsheng Miao, Bryan D Choi, Carter M Suryadevara, Luis Sanchez-Perez, Shicheng Yang, Gabriel De Leon, Elias J Sayour, Roger McLendon, James E Herndon, Patrick Healy, Gary E Archer, Darell D Bigner, Laura A Johnson, John H Sampson PloS One 2014, 9 (4): e94281

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma. Laura A Johnson, John Scholler, Takayuki Ohkuri, Akemi Kosaka, Prachi R Patel, Shannon E McGettigan, Arben K Nace, Tzvete Dentchev, Pramod Thekkat, Andreas Loew, Alina C Boesteanu, Alexandria P Cogdill, Taylor Chen, Joseph A Fraietta, Christopher C Kloss, Avery D Posey, Boris Engels, Reshma Singh, Tucker Ezell, Neeraja Idamakanti, Melissa H Ramones, Na Li, Li Zhou, Gabriela Plesa, John T Seykora, Hideho Okada, Carl H June, Jennifer L Brogdon, Marcela V Maus Science Translational Medicine 2015 February 18, 7 (275): 275ra22

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Bryan D Choi, Chien-Tsun Kuan, Mingqing Cai, Gary E Archer, Duane A Mitchell, Patrick C Gedeon, Luis Sanchez-Perez, Ira Pastan, Darell D Bigner, John H Sampson Proceedings of the National Academy of Sciences of the United States of America 2013 January 2, 110 (1): 270-5

Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Michael J Ciesielski, A Latif Kazim, Rolf F Barth, Robert A Fenstermaker Cancer Immunology, Immunotherapy: CII 2005, 54 (2): 107-19

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma. John H Sampson, Gary E Archer, Duane A Mitchell, Amy B Heimberger, Darell D Bigner Seminars in Immunology 2008, 20 (5): 267-75

T cells redirected to EphA2 for the immunotherapy of glioblastoma. Kevin K H Chow, Swati Naik, Sunitha Kakarla, Vita S Brawley, Donald R Shaffer, Zhongzhen Yi, Nino Rainusso, Meng-Fen Wu, Hao Liu, Yvonne Kew, Robert G Grossman, Suzanne Powell, Dean Lee, Nabil Ahmed, Stephen Gottschalk Molecular Therapy 2013, 21 (3): 629-37

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips